Urispas
Urinary Incontinence in Women on MedicineNet »
"Urinary incontinence (UI) in women facts
*Urinary incontinence (UI) in men facts Medically Edited by: Melissa Conrad Stöppler, MD
- The definition of urinary incontinence in women is the unintentional loss of urine."...
Read the entire article on MedicineNet »
© 1999-2013 MedicineNet, Inc All right reserved
Urispas
OVERDOSE
The oral LD50 for flavoxate HC1 in rats is 4273 mg/kg. The oral LD50 for flavoxate HC1 in mice is 1837 mg/kg. It is not known whether flavoxate HC1 is dialyzable.
CONTRAINDICATIONS
URISPAS® (flavoxate HC1) is contraindicated in patients who have any of the following obstructive conditions: pyloric or duodenal obstruction, obstructive intestinal lesions or ileus, achalasia, gastrointestinal hemorrhage and obstructive uropathies of the lower urinary tract.
Last reviewed on RxList: 6/12/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Urispas Information
Urispas - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Daily
Get breaking medical news.






